Novavax, Inc. (NVAX) is lower by Monday morning, with the stock losing -1.79% in pre-market trading to 157.6. NVAX's short-term technical score of 35 indicates that the stock has traded less bullishly over the last month than 65% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, NVAX ranks higher than 61% of stocks. Novavax, Inc. has risen 0.81% over the past month, closing at $173.02 on November 8. During this period of time, the stock fell as low as $160.48 and as high as $229.00. NVAX has an average analyst recommendation of Strong Buy. The company has an average price target of $260.60.
NVAX has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on NVAX!